electroCore (ECOR) announced that gammaCore Sapphire has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance in Belgium. Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical evidence supporting the therapy’s efficacy and cost-effectiveness and ensures broader access for Belgian patients.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECOR:
- electroCore announces Cuneo to depart from board, Errico to succeed as Chairman
- electroCore partners with iHeartRadio, former NY Jets linebacker Buttle
- Electrocore Expands Board with New Appointments
- electroCore appoints Elena Bonfiglioli to board of directors
- electroCore appoints Benning as SVP of Truvaga